Stockreport

Hims GLP 1 Deal With Novo Nordisk Reshapes Growth And Valuation Story [Yahoo! Finance]

Hims & Hers Health, Inc. Class A  (HIMS) 
PDF Hims & Hers Health (NYSE:HIMS) is expanding access to FDA-approved GLP-1 medications through a new collaboration with Novo Nordisk. The company is introducing a compr [Read more]